Current cutoffs for low disease activity in rheumatoid arthritis disease scores were evaluated and revised based on Boolean low disease activity criteria.
Between one-fifth and one-third of patients with rheumatoid arthritis, connective tissue disease, and vasculitis have ocular complications.
A novel study assesses the safety and efficacy of apremilast in patients with psoriasis and evaluates the treatment as a metabolic modulator.
A panel of experts provide their recommendations regarding the treatment of patients with rheumatologic skin disease during the COVID-19 pandemic.
A slightly increased risk for developing certain cancers was seen in patients with psoriasis.
A 17-item functional scale represents a new patient-reported outcome tool to assess global activities and participation in patients with systemic sclerosis.
Aortic stenosis was found to worsen more frequently in patients with vs without gout.
Recently released guidelines from Japan outline the factors that may influence the choice of biologic agents for treatment in patients with psoriasis.
Between 2000 and 2017, unintentional deaths and suicides related to opioid use have increased substantially, whereas overall deaths from have decreased.
Patients with hidradenitis suppurativa display increased risks for developing ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis, a study finds.
